查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1629875

全球診斷影像設備市場 - 2025-2033

Global Diagnostic Imaging Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球診斷影像設備市場規模達337億美元，預計2033年將達到526億美元，2025-2033年預測期間複合年成長率為5.1%。

診斷影像設備是一種醫療技術，用於創建身體內部的視覺表示，以進行臨床分析和醫療干預。這些設備透過提供器官、組織、骨骼和血管的詳細影像，在診斷、監測和治療各種醫療狀況方面發揮關鍵作用。它們是現代醫學的重要工具，因為它們可以幫助醫療保健提供者識別疾病、確定損傷程度、監測疾病進展以及計劃手術或治療。

在醫療保健需求增加、技術進步和慢性病盛行率不斷上升等多種因素的推動下，全球診斷影像市場需求強勁。例如，根據美國疾病管制與預防中心的數據，估計有 1.29 億美國人患有至少一種美國衛生部定義的主要慢性疾病（例如心臟病、癌症、糖尿病、肥胖、高血壓）和人類服務。在美國十大死亡原因中，有五個與可預防和可治療的慢性疾病密切相關。

市場動態：

驅動程式和限制

診斷影像設備不斷進步的技術

診斷影像設備不斷進步的技術進步極大地推動了診斷影像設備市場的成長，預計將在預測期內透過提高診斷準確性、效率和患者治療結果來推動市場發展。這些創新不僅增強了影像系統的功能，也擴展了其在各個臨床學科的應用。

人工智慧和機器學習透過提高影像分析的速度和準確性正在徹底改變診斷成像。人工智慧工具可以快速識別影像中的模式，協助檢測異常情況並為醫療保健專業人員提供決策支援。例如，2024 年 12 月，皇家飛利浦宣佈在該公司最近推出的 CT 5300 系統中提供人工智慧和智慧工作流程自動化功能的臨床決策支援。飛利浦CT 智慧工作流程具有一整套支援AI 的「精確」軟體解決方案，可協助CT 工作流程的每一步，將技術人員和放射科醫生從日常耗時的任務中解放出來，讓他們有更多時間專注於患者。

3D MRI 和 3D 超音波等技術改變了醫療保健專業人員可視化和診斷病情的方式。這些進步對於更好的手術規劃和疾病進展監測至關重要。例如，2024 年 5 月，Koelis, SAS 在著名的美國泌尿外科協會年會上發布了新功能，展示其將人工智慧增強的前列腺 MRI 功能整合到其獨家 Trinity 平台中的新穎能力。 Koelis Trinity 系統使泌尿科醫生能夠對前列腺癌進行 3D 靶向「融合活體組織切片」。 Trinity 將 3D 超音波成像與專有的 MRI-US 融合影像引導相整合，該影像引導採用該公司獨特的前列腺運動追蹤軟體 (OBT Fusion)。

可攜式診斷影像設備，例如手持式超音波機，正在改善獲得護理的機會，特別是在農村或服務不足的地區。這些設備具有移動性、成本效益以及在照護端進行診斷的能力，從而減少了患者長途跋涉前往醫療機構的需要。

例如，2023 年 2 月，Carestream Health India 推出了高效能 Carestream Motion 行動 X 光系統。本系統設備齊全，可進行全方位的一般放射線檢查。新型攜帶式成像系統結構緊湊，易於在狹小的空間內操作。管頭和鉸接臂等創新功能可實現出色的可視性且易於使用。

診斷影像設備成本高

診斷影像設備的高成本預計將阻礙市場成長，特別是在新興經濟體和小型醫療機構。 MRI、CT 掃描儀和 PET 掃描儀等診斷影像設備需要大量的前期投資，成本可能很高。這是一個重大障礙，特別是對於規模較小的醫療中心或財政資源有限的發展中地區的醫療中心而言。

例如，根據 Block Imaging, Inc. 的說法，CT 掃描器的平均成本根據型號和功能的不同而有很大差異，價格從基本型號的 80,000 美元到高級型號的高達 300,000 美元不等。通常，買家預計花費 12 萬至 16 萬美元購買一台中級 CT 掃描儀。 PET/CT 掃描儀的平均成本從入門級掃描儀的 225,000 美元到最佳化掃描系統的 475,000 美元不等。最新最好的 PET/CT 掃描儀價格高達 750,000 美元。

除了高昂的前期成本之外，這些成像設備還具有相當大的持續維護和營運費用。需要定期維護、軟體升級和維修，以保持設備高效運作。這增加了總體負擔，特別是在發展中經濟體，那裡的醫院和診斷中心可能已經在預算緊張的情況下掙扎。

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類的片段
  • 按成像類型分類的片段
  • 可移植性片段
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • 診斷影像設備不斷進步的技術
      • 慢性病盛行率上升和人口老化
    • 限制
      • 診斷影像設備成本高昂
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：診斷影像設備市場（依產品類型）

  • PET/CT 掃描儀
  • C型臂
  • 核磁共振機
  • 乳房X光攝影系統
  • 骨密度計
  • 其他

第 6 章：診斷影像設備市場（依影像類型）

  • X光影像
  • 電腦斷層掃描 (CT)
  • 磁振造影 (MRI)
  • 超音波
  • 核子造影
  • 乳房X光檢查
  • 其他

第 7 章：診斷影像設備市場（按便攜性）

  • 攜帶式設備
  • 手持裝置
  • 固定設備

第 8 章：診斷影像設備市場（按應用）

  • 心臟病學
  • 腫瘤學
  • 神經病學
  • 骨科
  • 泌尿科
  • 胃腸病學
  • 其他

第 9 章：診斷影像設備市場（按最終用戶）

  • 醫院
  • 診斷中心
  • 專科診所
  • 其他

第 10 章：診斷影像設備市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 12 章：公司簡介

  • Siemens Healthineers AG
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • GE HealthCare
  • Koninklijke Philips NV
  • CANON MEDICAL SYSTEMS CORPORATION
  • FUJIFILM Holdings Corporation
  • Medtronic plc
  • Hologic, Inc.
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Carestream Health

第 13 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 14 章：附錄

簡介目錄
Product Code: MD8905

The global diagnostic imaging devices market reached US$ 33.7 billion in 2024 and is expected to reach US$ 52.6 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

Diagnostic imaging devices are medical technologies used to create visual representations of the interior of a body for clinical analysis and medical intervention. These devices play a critical role in diagnosing, monitoring, and treating various medical conditions by providing detailed images of organs, tissues, bones, and blood vessels. They are crucial tools in modern medicine, as they help healthcare providers identify diseases, determine the extent of an injury, monitor disease progression, and plan surgeries or treatments.

The global diagnostic imaging market is experiencing robust demand, driven by various factors such as increasing healthcare needs, technological advancements and the growing prevalence of chronic diseases. For instance, according to the Centers for Disease Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Five of the top 10 leading causes of death in the US are or are strongly associated with preventable and treatable chronic diseases.

Market Dynamics: Drivers & Restraints

Rising technological advancements in diagnostic imaging devices

Rising technological advancements in diagnostic imaging devices are significantly driving the growth of the diagnostic imaging devices market and are expected to drive the market over the forecast period by improving diagnostic accuracy, efficiency and patient outcomes. These innovations not only enhance the capabilities of imaging systems but also expand their applications across various clinical disciplines.

AI and machine learning are revolutionizing diagnostic imaging by improving the speed and accuracy of image analysis. AI tools can quickly identify patterns in images, assist in detecting abnormalities and provide decision support to healthcare professionals. For instance, in December 2024, Royal Philips announced clinical decision-support with AI and smart workflow automation capabilities in the company's recently introduced CT 5300 system. Philips' CT Smart Workflow features a comprehensive suite of AI-enabled 'Precise' software solutions that assist at every step of the CT workflow, freeing technicians and radiologists from routine, time-consuming tasks and allowing them more time to focus on their patients.

Technologies like 3D MRI and 3D ultrasound have transformed how healthcare professionals visualize and diagnose conditions. These advancements are crucial for better surgical planning and monitoring of disease progression. For instance, in May 2024, Koelis, SAS released new features at the prestigious American Urological Association Annual Meeting to demonstrate its novel capacity to integrate AI-enhanced prostate MRI features into its exclusive Trinity platform. The Koelis Trinity system enables urologists to perform 3D targeted "fusion biopsy" in prostate cancer. Trinity integrates 3D ultrasound imaging with proprietary MRI-US fusion image guidance that features the Company's unique prostate motion tracking software (OBT Fusion).

Portable diagnostic imaging devices, such as handheld ultrasound machines, are improving access to care, especially in rural or underserved areas. These devices offer mobility, cost-effectiveness, and the ability to perform diagnostics at the point of care, reducing the need for patients to travel long distances to healthcare facilities.

For instance, in February 2023, Carestream Health India launched its high-powered Carestream Motion Mobile X-ray system. The system is fully equipped to carry out a full range of general radiography examinations. The new portable imaging system is compact and easy to maneuver into tight spaces. Innovative features such as a tube head and articulating arm for excellent visibility and easy use.

High cost of diagnostic imaging devices

The high cost of diagnostic imaging devices is expected to hamper the market growth, especially in emerging economies and small healthcare facilities. Diagnostic imaging devices such as MRI, CT scanners, and PET scanners require substantial upfront investments, which can be cost highly. This is a significant barrier, particularly for smaller healthcare centers or those in developing regions with limited financial resources.

For instance, according to Block Imaging, Inc., the average cost for a CT scanner varies significantly depending on the model and features, with prices ranging from $80,000 for basic models to up to $300,000 for premium. Typically, buyers can expect to spend between $120,000 and $160,000 for an intermediate-level CT scanner. The average cost of a PET/CT scanner can range from $225,000 for an entry-level scanner to $475,000 for an optimized scanning system. PET/CT scanners can go as high as $750,000 for the latest and greatest.

In addition to high upfront costs, these imaging devices have considerable ongoing maintenance and operational expenses. Regular servicing, software upgrades and repairs are required to keep the equipment functioning efficiently. This adds to the overall burden, especially in developing economies where hospitals and diagnostic centers may already be struggling with tight budgets.

Segment Analysis

The global diagnostic imaging devices market is segmented based on product type, imaging type, portability, application, end-user and region.

Product Type:

The PET/CT scanners segment is expected to dominate the diagnostic imaging devices market share

The PET/CT scanners segment is expected to dominate the global diagnostic imaging devices market. PET/CT scanners combine Positron Emission Tomography (PET) and Computed Tomography (CT), allowing physicians to obtain both functional and anatomical images in a single scan. This fusion of technologies enables on-site technological upgrades, more accurate detection, staging and monitoring of diseases.

For instance, in July 2024, Positron announced that the company is launching its NeuSight PET/CT 3D 64-slice scanner in the U.S. and North American markets. Suitable for both cardiology and oncology imaging, the NeuSight PET/CT scanner offers anatomic and functional imaging for heart, tumor and brain imaging studies.

Continuous advancements in PET/CT scanner technology are making these devices more efficient and accessible. Innovations such as higher-resolution imaging, faster scan times, and improved patient comfort are boosting the adoption of these devices. For instance, in June 2024, Siemens Healthineers unveiled its latest PET/CT scanner, cleared by the U.S. Food and Drug Administration and features a scalable axial field-of-view design that enables on-site technological upgrades without costly room renovations or impeding workflow.

Geographical Analysis

North America is expected to hold a significant position in the diagnostic imaging devices market share

North America is expected to hold the largest market share in the global diagnostic imaging devices market. North America especially the United States is often the first region to adopt new diagnostic imaging technologies, including advanced MRI systems, digital X-rays and AI-powered imaging devices along with the strong presence of major players. The early adoption of innovations allows North America countries to maintain their leadership in the global market.

For instance, in October 2024, FUJIFILM Healthcare Americas Corporation launched the Version 10 (v10) suite of innovations for the ECHELON Synergy 1.5T MRI system. ECHELON Synergy v10 deploys several cutting-edge technologies, including Synergy DLR Clear, Synergy Vision with StillShot and automated scanning process enhancements.

North America, particularly the United States hosts some of the world's largest diagnostic imaging device manufacturers, such as GE Healthcare, Philips Healthcare, Siemens Healthineers and Canon Medical Systems. These companies invest heavily in research and development (R&D) to create next-generation imaging systems that continue to push the boundaries of diagnostic capabilities.

For instance, in December 2024, GE HealthCare unveiled Sonic DL for 3D, a new deep-learning innovation for the company's imaging portfolio. GE HealthCare initially launched Sonic DL in 2023. The company says it provides up to 12 times scan acceleration while maintaining diagnostic quality. This latest enhancement brings the system to 3D volumetric imaging. GE HealthCare wants to broaden the platform's applicability to brain, spine, orthopedic and body exams in addition to cardiac.

Asia-Pacific is growing at the fastest pace in the diagnostic imaging devices market

The Asia-Pacific region is experiencing the fastest growth in the diagnostic imaging devices market. The region is rapidly adopting advanced diagnostic imaging technologies, including AI-powered imaging devices, portable ultrasound machines and hybrid systems (e.g., PET/CT). These innovations are making diagnostic imaging more efficient, affordable and accessible in the region.

For instance, in October 2023, Abbott launched its new vascular imaging platform powered by Ultreon 1.0 Software in India. This first-of-its-kind intra-vascular imaging software combines optical coherence tomography (OCT) with the power of artificial intelligence (AI) providing physicians a comprehensive view of blood flow and blockages within coronary arteries. The innovative imaging software can automatically differentiate between a calcified and non-calcified blockage, detect the severity of calcium-based blockages and measure vessel diameter.

Additionally, in July 2024, Trivitron Healthcare launched its Terrene CT scanner in India. The scanner has received approvals from the Bureau of Indian Standards, Atomic Energy Regulatory Board, and Central Drugs Standard Control Organization, marking a significant milestone in the Indian healthcare industry.

Competitive Landscape

The major global players in the diagnostic imaging devices market include Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Medtronic plc, Hologic, Inc., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Carestream Health and among others.

Key Developments

  • In August 2024, Fischer Medical Ventures (FMVL) introduced indigenously developed Computed Tomography (CT) scans. The company developed India's first indigenous Magnetic Resonance Imaging (MRI) system. The company, celebrating its listing on the Bombay Stock Exchange (BSE), announced plans to introduce domestically produced CT scans in collaboration with Edusoft at half the price of current market offerings.
  • In July 2024, LG Electronics (LG) announced that the company expanding its lineup of diagnostic monitors with the new 21HQ613D-B, which was recently cleared by the U.S. Food and Drug Administration for sale in the U.S. Intended for digital mammography and digital breast tomosynthesis, the 21HQ613D-B is a 21.3-inch 5-megapixel (MP) IPS diagnostic monitor designed to deliver high-definition radiological images and maintains consistent image quality through its internal front calibration sensor and calibration software.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews clinical trials, product pipelines, and future advancements in medical devices.
  • Product Performance & Market Positioning: Analyzes product performance and market positioning to refine strategies.
  • Real-World Evidence: Uses patient feedback and data to improve device outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and health system mergers' impact on adoption.
  • Market Updates & Industry Changes: Covers regulatory changes, new policies, and emerging technologies in medical devices.
  • Competitive Strategies: Analyzes competitor strategies, market share, and new entrants in the market.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and access strategies.
  • Market Entry & Expansion: Identifies strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights regions with growth opportunities and investment potential.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and regulatory changes.
  • Post-market Surveillance: Uses post-market data to enhance device safety and access.
  • Cost-Effectiveness & Value-Based Healthcare: Analyzes cost-effectiveness and value-based models in device pricing and adoption.

The global diagnostic imaging devices market report delivers a detailed analysis with 78 key tables, more than 84 visually impactful figures, and 183 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Imaging Type
  • 2.5. Snippet by Portability
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in Diagnostic Imaging Devices
      • 3.1.1.2. Rising Prevalence of Chronic Diseases and Aging Population
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Diagnostic Imaging Devices
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Diagnostic Imaging Devices Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. PET/CT Scanners*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. C-Arms
  • 5.4. MRI Machines
  • 5.5. Mammography Systems
  • 5.6. Bone Densitometers
  • 5.7. Others

6. Diagnostic Imaging Devices Market, By Imaging Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 6.1.2. Market Attractiveness Index, By Imaging Type
  • 6.2. X-Ray Imaging*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Computed Tomography (CT)
  • 6.4. Magnetic Resonance Imaging (MRI)
  • 6.5. Ultrasound
  • 6.6. Nuclear Imaging
  • 6.7. Mammography
  • 6.8. Others

7. Diagnostic Imaging Devices Market, By Portability

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 7.1.2. Market Attractiveness Index, By Portability
  • 7.2. Portable Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Handheld Devices
  • 7.4. Stationary Equipments

8. Diagnostic Imaging Devices Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Oncology
  • 8.4. Neurology
  • 8.5. Orthopedics
  • 8.6. Urology
  • 8.7. Gastroenterology
  • 8.8. Others

9. Diagnostic Imaging Devices Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. Diagnostic Imaging Devices Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Siemens Healthineers AG*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. GE HealthCare
  • 12.3. Koninklijke Philips N.V.
  • 12.4. CANON MEDICAL SYSTEMS CORPORATION
  • 12.5. FUJIFILM Holdings Corporation
  • 12.6. Medtronic plc
  • 12.7. Hologic, Inc.
  • 12.8. Abbott Laboratories
  • 12.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 12.10. Carestream Health

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us